Evidence Summary

What is an Evidence Summary?

Key messages from scientific research that's ready to be acted on

Got It, Hide this
  • Rating:

Low doses of testosterone may improve sexual function and desire in postmenopausal women

Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7:754-66.

Review questions

Does treatment with testosterone improve sexual function In women? Does it affect body weight or cholesterol levels?


Women sometimes have problems with sexual functioning. Problems can include low levels of desire or arousal, pain when having sex, or difficulty having orgasm. These may be more likely to happen after menopause but can happen for many reasons at any time of life. When these problems don’t go away, keep coming back, or cause distress, they may be considered sexual dysfunction. Women who are worried or upset about changes in their sexual functioning should talk to their doctor. This review looks at whether one treatment, testosterone, can improve symptoms of sexual dysfunction in women.

How the review was done

The researchers did a systematic review of studies available up to December 2018. They found 36 randomized controlled trials that included 8,480 adult women. Most women had gone through menopause, either naturally or because of surgery.

The key features of the studies were:

  • testosterone was mostly given orally (in combination with other hormone therapies) or using a skin patch; it was also given in the form of a cream, gel, spray, or intramuscular injection;
  • testosterone was given in low doses (mostly 1.25 to 2.5 mg/day orally or 300 µg daily or twice weekly with skin patches) and compared with placebo or other hormone therapies; and
  • most women were treated for about 4 to 6 months (range 12 weeks to 2 years).

What the researchers found

Compared with placebo or other hormone therapies, testosterone:

  • increased sexual function and desire by a small amount;
  • increased low-density lipoprotein cholesterol (the type of cholesterol that increases the risk for heart disease) when given orally;
  • increased body weight by about 0.5 kg; and
  • increased risk for acne and extra hair growth.


In postmenopausal women, testosterone may improve sexual function and desire by a small amount compared with placebo or other hormone therapies. Testosterone can worsen some cholesterol levels when given orally, and it also increases body weight. We need more studies using low doses of testosterone to be confident about its effects. (Testosterone doses currently available in most countries are intended for men and are too high for women.)

Testosterone vs control (placebo or other hormone therapies) in postmenopausal women


Effects of testosterone

Sexual function

Increased number of satisfying sexual events by about 1 per month (8 trials with 3,238 women)


Small improvement in sexual desire (15 trials with 3,762 women), arousal (11 trials with 3,271 women), orgasm (11 trials with 3,289 women), responsiveness (8 trials with 3,212 women), and sexual distress (7 trials with 2,886 women)


Improved scores for pleasure (7 trials with 3,006 women), sexual self-image (7 trials with 2,997 women), and sexual concerns (7 trials with 3,009 women)


Increased LDL-C levels (the type of cholesterol that increases risk for heart disease) when given orally (9 trials with 637 women)


No effect on LDL-C levels when not given orally (mainly using a patch or cream) (10 trials with 1,768 women)

Body weight

Increased weight by about 0.5 kg (5 trials with 2,032 women)

Adverse events

Increased risk for acne (10 trials with 3,264 women) and extra hair growth (11 trials with 4,178 women) but did not increase risk for alopecia (hair loss) (5 trials with 2,459 women), voice changes (5 trials with 2,587 women), enlarged clitoris (3 trials with 1,643 women), or serious adverse events (9 trials with 4,063 women)

LDL-C = low-density lipoprotein cholesterol.

Related Topics


A harmless, inactive, and simulated treatment.
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
Systematic review
A comprehensive evaluation of the available research evidence on a particular topic.

Related Web Resources

  • Healthy Bones: A Decision Aid for Women After Menopause

    This patient decision aid helps women who have gone through menopause and may have osteoporosis decide on methods to keep your bones healthy. It facilitates the process by outlining and comparing the choices such as medicine, menopausal hormone therapy (MHT), and exercise.
  • Breast cancer: Risks and benefits, age 50-69

    Canadian Task Force on Preventive Health Care
    Your risk of dying from breast cancer is slightly reduced if you have regular screening. However, regular screening increases your chance of a false positive result, a biopsy and having part or all of a breast removed unnecessarily.
  • Breast cancer: Patient algorithm

    Canadian Task Force on Preventive Health Care
    The Canadian Task Force on Preventive Health Care recommends women between 50 and 74 years old who are not at high risk get screened for breast cancer every 2 to 3 years. Talk to your doctor about screening options if you are at high risk or over 74 years old.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal (

Register for free access to all Professional content